Literature DB >> 15966223

Modified diagnostic criteria of drug-induced liver injury proposed by the international consensus meeting.

Motoh Iwasa1, Mikio Zeniya, Teru Kumagi, Akiko Hisamochi, Hiroshi Yasuda, Meiko Nishiuchi, Naoaki Akisawa, Naoki Mantani, Masaaki Watanabe, Tadashi Ito, Atsushi Nakamura, Hajime Takikawa, Yukihiko Adachi.   

Abstract

BACKGROUND/AIMS: The usefulness of the diagnostic criteria of the International Consensus Meeting (criteria A) has been previously reported. However, these criteria are not clinically adaptable in Japan where allergic reaction is one of the major etiologies of drug-induced liver injury and thus it was revised and reported in the Digestive Disease Week-Japan of 2002 as DDW-J criteria (criteria B). It remains controversial whether the revised criteria can exclude drugs not causing liver injury.
METHODOLOGY: Two new diagnostic criteria (criteria C and D) were designed to supplement the DDW-J criteria. Usefulness and limitations of the four criteria were retrospectively examined using cases of drug-induced liver injury experienced in 8 hospitals.
RESULTS: It was confirmed that the sensitivity of criteria B is excellent for diagnosis of drug-induced liver injury. However, diagnostic criteria B were found to be disadvantageous in relation to specificity, while diagnostic criteria D were disadvantageous in relation to sensitivity. Sensitivity of diagnostic criteria C was a little superior to that of diagnostic criteria A.
CONCLUSIONS: On the basis, the significant sensitivity of criteria B was confirmed again, however, modification should be done for increasing specificity. Criteria C appear to be the best for their sensitivity and specificity.

Entities:  

Mesh:

Year:  2005        PMID: 15966223

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Role of Transient Elastography (Fibroscan) in Differentiating Severe Acute Hepatitis and Acute on Chronic Liver Failure.

Authors:  Praveen Sharma; Rinkesh Bansal; Abdul Matin; Pankaj Tyagi; Naresh Bansal; Vikas Singla; Ashish Kumar; Anil Arora
Journal:  J Clin Exp Hepatol       Date:  2015-10-01

2.  Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy.

Authors:  Yasoo Sugiura; Etsuo Nemoto; Osamu Kawai; Yasuyuki Ohkubo; Hisae Fusegawa; Shizuka Kaseda
Journal:  Lung Cancer (Auckl)       Date:  2013-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.